Taking the Patient-Centered Approach to Mycophenolate Risk Mitigation
Cara Dolin, MD
Jennifer Simpson
Diana Girnita, MD ,PhD
Pinpointing the Top Questions about Biosimilars in Rheumatology
Leonard H. Calabrese, DO
John R. Tesser, MD
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.